Maria Isabel Morosini
Overview
Explore the profile of Maria Isabel Morosini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Candela A, Guerrero-Lopez A, Mateos M, Gomez-Asenjo A, Arroyo M, Hernandez-Garcia M, et al.
J Clin Microbiol
. 2023 Apr;
61(4):e0104922.
PMID: 37014210
The Enterobacter cloacae complex (ECC) encompasses heterogeneous clusters of species that have been associated with nosocomial outbreaks. These species may have different acquired antimicrobial resistance and virulence mechanisms, and their...
2.
Castillo-Polo J, Hernandez-Garcia M, Morosini M, Perez-Viso B, Soriano C, de Pablo R, et al.
J Antimicrob Chemother
. 2023 Mar;
78(5):1259-1264.
PMID: 36964710
Objectives: Ceftazidime/avibactam and cefiderocol are two of the latest antibiotics with activity against a wide variety of Gram-negatives, including carbapenem-resistant Enterobacterales. We sought to describe the phenotypic and genotypic characteristics...
3.
Erdem F, Diez-Aguilar M, Oksuz L, Kayacan C, Abulaila A, Oncul O, et al.
Acta Microbiol Immunol Hung
. 2022 Jul;
69(3):215-219.
PMID: 35895557
Treatment of infections caused by OXA-48 carbapenemase producing multidrug-resistant isolates often necessitates combination therapy. In vitro effect of different antibiotic combinations against multidrug-resistant (MDR) Klebsiella pneumoniae isolates were evaluated in...
4.
Hernandez-Garcia M, Castillo-Polo J, Cordero D, Perez-Viso B, Garcia-Castillo M, Fuente J, et al.
J Clin Microbiol
. 2022 Feb;
60(3):e0224521.
PMID: 35107303
The emergence of Klebsiella pneumoniae isolates carrying novel variants conferring ceftazidime-avibactam (CAZ/AVI) resistance is being increasingly reported. We evaluated the accuracy of phenotypic methods commonly used in routine clinical laboratories...
5.
Hernandez-Garcia M, Diaz-Agero C, Perez-Viso B, Sanchez A, Lopez-Fresnena N, Morosini M, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2021 Nov;
39(9):429-435.
PMID: 34736747
Introduction: The lack of consensus of control measures to prevent extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) transmission in the hospital setting is of great concern. We describe the prevalence and species...
6.
Garcia-Caballero A, de Dios Caballero J, Maruri A, Serrano-Tomas M, Del Campo R, Morosini M, et al.
Diagn Microbiol Infect Dis
. 2021 Oct;
102(1):115559.
PMID: 34662789
Methicillin-resistant Staphylococcus aureus (MRSA) detection in cystic fibrosis (CF) is challenging. We compared different phenotypic methods among 157 S. aureus from 136 CF-patients: cefoxitin (FOX) and oxacillin (OXA) broth-microdilution; MicroScan-WalkAway®;...
7.
Pintado V, Ruiz-Garbajosa P, Escudero-Sanchez R, Gioia F, Herrera S, Vizcarra P, et al.
Infect Dis (Lond)
. 2021 Aug;
54(1):36-45.
PMID: 34382910
Background: Carbapenemase-producing (CPE) infections have been occasionally described in patients with coronavirus disease-19 (COVID-19). We assess the clinical features and outcome of these infections. Methods: In this retrospective single-centre, case-control...
8.
Evaluation of Rapid Polymyxin test in clinical isolates with various degrees of multidrug resistance
Sanchez-Lopez J, Cortes-Cuevas J, Diez-Aguilar M, Lopez-Causape C, Canton R, Morosini M
JAC Antimicrob Resist
. 2021 Jul;
3(3):dlab104.
PMID: 34316679
Background: is of great concern among MDR bacteria and rapid and reliable antibiotic susceptibility testing methods are extremely necessary. Colistin is, in many cases, among the limited useful alternatives for...
9.
Hernandez-Garcia M, Sanchez-Lopez J, Martinez-Garcia L, Becerra-Aparicio F, Morosini M, Ruiz-Garbajosa P, et al.
Pathogens
. 2021 Jan;
10(1).
PMID: 33466574
We report the emergence of an isolate belonging to the sequence type (ST)131- high-risk clone with ceftazidime-avibactam resistance recovered from a patient with bacteremia in 2019. Antimicrobial susceptibility was determined...
10.
Escudero-Sanchez R, Ponce-Alonso M, Barragan-Prada H, Morosini M, Canton R, Cobo J, et al.
Genes (Basel)
. 2021 Jan;
12(1).
PMID: 33396759
The aim was to describe the safety of indefinite administration of antibiotics, the so-called suppressive antibiotic therapy (SAT) and to provide insight into their impact on gut microbiota. 17 patients...